Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).

A multicentric, prospective phase III study was carried out with the aim of testing the so-called 'worst drug rule' hypothesis, which suggests the use of an effective but 'less active' regimen that first eradicates tumoral cells resistant to a second effective and 'more acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Colucci, G., Gebbia, V., Galetta, D., Riccardi, F., Cariello, S., Gebbia, N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228170/
https://www.ncbi.nlm.nih.gov/pubmed/9400950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228170/
https://www.ncbi.nlm.nih.gov/pubmed/9400950

Ejemplares similares